Skip to main content

Table 1 Baseline characteristics of participants

From: A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors

Characteristics N = 15
Median age (range, years) 51.3 (27–71)
Age group, years, n (%)  
49 and Under 7 (46.7)
50 to 59 4 (26.7)
60 and Above 4 (26.7)
Gender n (%)  
Male 5 (33.3)
Female 10 (66.7)
ECOG performance status n (%)  
0 3 (20)
1 12 (80)
Tumor type, n (%)  
Esophageal cancer 1 (6.7)
Gastric cancer 2 (13.3)
Colon cancer 5 (33.3)
Rectum cancer 2 (13.3)
Breast cancer 3 (20.0)
Soft tissue sarcoma 2 (13.3)